Page last updated: 2024-08-24

ursolic acid and Astrocytoma, Grade IV

ursolic acid has been researched along with Astrocytoma, Grade IV in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, Q; Deng, G; Li, Y; Liu, B; Song, P; Zhao, L; Zhao, Q; Zhou, L; Zhou, Y1
Huang, BR; Liao, PJ; Lu, CC; Yen, GC1
Jiang, C; Li, Y; Wang, J; Wang, X1

Other Studies

3 other study(ies) available for ursolic acid and Astrocytoma, Grade IV

ArticleYear
Ursolic acid nanoparticles for glioblastoma therapy.
    Nanomedicine : nanotechnology, biology, and medicine, 2023, Volume: 50

    Topics: Animals; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Mice; Nanoparticles; Ursolic Acid

2023
Ursolic acid triggers nonprogrammed death (necrosis) in human glioblastoma multiforme DBTRG-05MG cells through MPT pore opening and ATP decline.
    Molecular nutrition & food research, 2014, Volume: 58, Issue:11

    Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Cyclophilins; Cyclosporine; DNA Damage; Glioblastoma; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Necrosis; Peptidyl-Prolyl Isomerase F; Reactive Oxygen Species; Signal Transduction; Triterpenes; Ursolic Acid

2014
Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-β1/miR-21/PDCD4 pathway.
    Basic & clinical pharmacology & toxicology, 2012, Volume: 111, Issue:2

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Humans; MicroRNAs; Real-Time Polymerase Chain Reaction; RNA-Binding Proteins; Signal Transduction; Transforming Growth Factor beta1; Triterpenes; Ursolic Acid

2012